|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print August 29, 2002
Am J Physiol Regu Physiol, 10.1152/ajpregu.00172.2002
Submitted on March 18, 2002
Accepted on August 13, 2002
1 Department of Pediatrics, Mattel Children's Hospital, David Geffen School of Medicine @ UCLA, Los Angeles, CA, USA
2 Department of Pediatrics, The University of Arizona College of Medicine, Tucson, AZ, USA
3 Department of Microbiology and Immunology, The Universitiy of Arizona College of Medicine, Tuscon, AZ, USA
4 Department of Pediatrics, University of California at Davis, Sacramento, CA, USA
* To whom correspondence should be addressed. E-mail: rlane{at}mednet.ucla.edu.
Milk-borne Insulin-Like Growth Factors (IGF) enhance nutrient absorption in the immature intestine, which is characterized by low levels of glucose oxidation. We therefore hypothesized that feeding a rat milk substitute (RMS) devoid of growth factors to rat pups would lower serum glucose levels relative to dam-fed control rats, and that supplementation of RMS with physiological doses of either IGF-I or IGF-II would normalize serum glucose levels via increased jejunal glucose transporter 2 (GLUT2) and high affinity Na+-glucose co-transporter (SGLT1) expression. We found lower serum glucose concentrations in RMS-fed pups; in contrast, serum glucose levels in the IGF supplemented pups were similar to those of dam fed controls. RT-PCR and laser scanning confocal microscopy similarly demonstrated that IGF supplementation increased expression of jejunal glucose transporters. Further experiments demonstrated that IGF supplementation altered mRNA levels of key mitochondrial enzymes without altering jejunal lactase activity. We conclude that IGF-I and IGF-II supplementation increases serum glucose levels in the immature rat pup fed artificial formula and alters gene expression of the jejunal glucose transporters.
This article has been cited by other articles:
![]() |
C. E. Commare and K. A. Tappenden Development of the Infant Intestine: Implications for Nutrition Support Nutr Clin Pract, April 1, 2007; 22(2): 159 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sandu, F. Artunc, M. Palmada, R. Rexhepaj, F. Grahammer, A. Hussain, C. Yun, D. R. Alessi, and F. Lang Impaired intestinal NHE3 activity in the PDK1 hypomorphic mouse Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G868 - G876. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Artunc, R. Rexhepaj, H. Volkl, F. Grahammer, C. Remy, D. Sandulache, O. Nasir, C. A. Wagner, D. R. Alessi, and F. Lang Impaired intestinal and renal glucose transport in PDK-1 hypomorphic mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1533 - R1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grahammer, G. Henke, C. Sandu, R. Rexhepaj, A. Hussain, B. Friedrich, T. Risler, M. Metzger, L. Just, T. Skutella, et al. Intestinal function of gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1 Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1114 - G1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ke, Q. Lei, S. J. James, S. L. Kelleher, S. Melnyk, S. Jernigan, X. Yu, L. Wang, C. W. Callaway, G. Gill, et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats Physiol Genomics, March 13, 2006; 25(1): 16 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ke, R. A. McKnight, Z.-m. Wang, X. Yu, L. Wang, C. W. Callaway, K. H. Albertine, and R. H. Lane Nonresponsiveness of cerebral p53-MDM2 functional circuit in newborn rat pups rendered IUGR via uteroplacental insufficiency Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1038 - R1045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |